Bill Snyder Archive — Page 99 of 118
-
July 24, 2014
Magnuson honored for role in Beta Cell Biology Consortium
Mark Magnuson, M.D., Louise B. McGavock Professor of Molecular Physiology and Biophysics at Vanderbilt University, has received a national leadership award for the Beta Cell Biology Consortium (BCBC), a major team science initiative. -
July 24, 2014
VU’s technology transfer efforts gain steam
Vanderbilt University signed 101 licensing agreements with industry partners in fiscal year 2014, nearly 20 more than the record total set last year. -
July 24, 2014
Team effort boosts study of tachycardia syndrome
Vanderbilt University’s Satish Raj, M.D., MSCI, was very busy — and very visible — at the Dysautonomia International Conference in Washington, D.C., earlier this month. -
July 24, 2014
Colon cancer’s protein signatures identified
A Vanderbilt University-led research team has identified protein “signatures” of genetic mutations that drive colorectal cancer, the nation’s second leading cause of cancer deaths after lung cancer. -
July 17, 2014
Breast tissue growth protein may promote cancer: study
A protein essential for growth of normal breast tissue also may play a role in breast cancer, Vanderbilt University researchers have found. -
July 10, 2014
VU, Celgene announce research partnership
Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market.